Researchers hope streamlined regulations will reverse decline in medical studies across Europe.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Evaluating the impact of Brexit on the pharmaceutical industry
Journal of Pharmaceutical Policy and Practice Open Access 04 October 2017
-
Barriers to the conduct of randomised clinical trials within all disease areas
Trials Open Access 01 August 2017
Access options
Subscribe to this journal
Receive 51 print issues and online access
199,00 € per year
only 3,90 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Cressey, D. Overhaul complete for EU clinical trials. Nature (2014). https://doi.org/10.1038/nature.2014.15339
Published:
DOI: https://doi.org/10.1038/nature.2014.15339
This article is cited by
-
Evaluating the impact of Brexit on the pharmaceutical industry
Journal of Pharmaceutical Policy and Practice (2017)
-
Barriers to the conduct of randomised clinical trials within all disease areas
Trials (2017)
